-
specific cell types with minimal off-target effects, EVs are currently being investigated for their broad use as drug/gene delivery vehicles and as therapeutic agents in numerous disease types [2]. Robust
-
NIST only participates in the February and August reviews. The development of therapies and other products based on pluripotent stem cells requires control of the pluripotent and differentiated
-
models intractable; 2) sensitive, deformable components that exhibit compositional disorder and nonlinear responses; and 3) active agents capable of self-propulsion, creating systems that are inherently
-
systems; Networks; Cyber security; Performance analysis; Resource allocation; Optimization; Agent-based modeling; Game theory; Statistical physics; Eligibility citizenship Open to U.S. citizens level Open
-
., sociology, planning, decision science), and public health science (e.g., disaster epidemiology, biostatistics). Agent-based Modeling; Applied Economics; Benefit-Cost Analysis; Buildings; Community Resilience
-
Description Cell viability is a crucial measurement for advanced therapies such as cell and gene therapies and regenerative medicine, where live cells are the therapeutic agent. Cell viability measurements